HANGZHOU TIGERMED CO. H 1 Cash Flow-to-Debt Ratio
HANGZHOU TIGERMED CO. H 1 cash flow-to-debt ratio. HANGZHOU TIGERMED CO. H 1 (5HZ1) has a Cash Flow-to-Debt Ratio of 0.27x as of December 2025, meaning its operating cash flow of €1.12 Billion could theoretically repay 0% of its total liabilities (€4.10 Billion) in one year. Check earnings quality score of HANGZHOU TIGERMED CO. H 1 to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of HANGZHOU TIGERMED CO. H 1 (2021–2025)
Cash flow-to-debt ratio of HANGZHOU TIGERMED CO. H 1 from 2021 to 2025. Historical debt coverage capacity for HANGZHOU TIGERMED CO. H 1 across 5 annual periods. Check HANGZHOU TIGERMED CO. H 1 (5HZ1) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
HANGZHOU TIGERMED CO. H 1 Cash Flow-to-Debt Ratio by Year (2021–2025)
HANGZHOU TIGERMED CO. H 1 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for HANGZHOU TIGERMED CO. H 1. For the full cash flow conversion analysis, see HANGZHOU TIGERMED CO. H 1 cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | €1.12 Billion | €4.10 Billion | ▲ +14.4% |
| 2024 | 0.24x | €1.10 Billion | €4.61 Billion | ▲ +8.2% |
| 2023 | 0.22x | €1.15 Billion | €5.23 Billion | ▼ -22.7% |
| 2022 | 0.28x | €1.36 Billion | €4.77 Billion | ▼ -37.3% |
| 2021 | 0.45x | €1.42 Billion | €3.14 Billion | — |